Thirty years ago, astronomers weren’t sure planets beyond our solar system even existed. This year, NASA has confirmed its ...

Discover why Lyell Immunopharma (LYEL) stock is up 191% YTD. Explore CAR T therapy breakthroughs, trial milestones, and key investment insights.

Researchers at MIT have unveiled a way to temporarily reboot aging immune systems, using a targeted mRNA therapy that turns ...

Independent practices face challenges from consolidation and policy shifts, with hybrid models offering autonomy while sharing financial risk. Value-based care in oncology prioritizes science, ...

CAR T-cell therapy has revolutionized the treatment of certain hematologic malignancies, providing durable remissions for ...

Kyverna Therapeutics is upgraded to Buy based on strengthened financials and the potential for commercial launch by the end ...

Miguel-Angel Perales, MD, spoke with Targeted Oncology® about the problems the CAR T Vision group has identified and the key ...

Such an advancement would allow for one of the most successful non-chemo cancer treatments to be done both faster and cheaper ...

As of Thursday, December 18, Century Therapeutics, Inc.’s IPSC share price has surged by 12.35%, which has investors ...

CellVoyant, a U.K.-based startup, has launched an AI platform that allows scientists to predict the future health and ...

While autologous therapies are mainstream in blood cancers, experts warn against overhyping allogeneic and in vivo approaches ...

During a live event, Matthew Lunning, DO, discussed key factors that determine whether patients should receive CAR T-cell ...